ABSTRACT Abasic (AP) sites are major DNA lesions and are highly mutagenic. AP site-induced mutagenesis largely depends on translesion synthesis. We have examined the role of DNA polymerase h (Polh) in translesion synthesis of AP sites by replicating a plasmid containing a site-specific AP site in yeast cells. In wild-type cells, AP site bypass resulted in preferred C insertion (62%) over A insertion (21%), as well as À1 deletion (3%), and complex event (14%) containing multiple mutations. In cells lacking Polh (rad30), Rev1, Polz (rev3 ), and both Polh and Polz, translesion synthesis was reduced to 30%, 30%, 15% and 3% of the wild-type level, respectively. C insertion opposite the AP site was reduced in rad30 mutant cells and was abolished in cells lacking Rev1 or Polz, but significant A insertion was still detected in these mutant cells. While purified yeast Pola effectively inserted an A opposite the AP site in vitro, purified yeast Pold was much less effective in A insertion opposite the lesion due to its 3 0 !5 0 proofreading exonuclease activity. Purified yeast Polh performed extension synthesis from the primer 3 0 A opposite the lesion. These results show that Polh is involved in translesion synthesis of AP sites in yeast cells, and suggest that an important role of Polh is to catalyze extension following A insertion opposite the lesion. Consistent with these conclusions, rad30 mutant cells were sensitive to methyl methanesulfonate (MMS), and rev1 rad30 or rev3 rad30 double mutant cells were synergistically more sensitive to MMS than the respective single mutant strains.
ABSTRACT
Abasic (AP) sites are major DNA lesions and are highly mutagenic. AP site-induced mutagenesis largely depends on translesion synthesis. We have examined the role of DNA polymerase h (Polh) in translesion synthesis of AP sites by replicating a plasmid containing a site-specific AP site in yeast cells. In wild-type cells, AP site bypass resulted in preferred C insertion (62%) over A insertion (21%), as well as À1 deletion (3%), and complex event (14%) containing multiple mutations. In cells lacking Polh (rad30), Rev1, Polz (rev3 ), and both Polh and Polz, translesion synthesis was reduced to 30%, 30%, 15% and 3% of the wild-type level, respectively. C insertion opposite the AP site was reduced in rad30 mutant cells and was abolished in cells lacking Rev1 or Polz, but significant A insertion was still detected in these mutant cells. While purified yeast Pola effectively inserted an A opposite the AP site in vitro, purified yeast Pold was much less effective in A insertion opposite the lesion due to its 3 0 !5 0 proofreading exonuclease activity. Purified yeast Polh performed extension synthesis from the primer 3 0 A opposite the lesion. These results show that Polh is involved in translesion synthesis of AP sites in yeast cells, and suggest that an important role of Polh is to catalyze extension following A insertion opposite the lesion. Consistent with these conclusions, rad30 mutant cells were sensitive to methyl methanesulfonate (MMS), and rev1 rad30 or rev3 rad30 double mutant cells were synergistically more sensitive to MMS than the respective single mutant strains.
INTRODUCTION
Apurinic/apyrimidinic (AP) sites, also referred to as abasic sites, are a major type of spontaneous DNA lesions. Some environmental agents, such as methyl methanesulfonate (MMS), can also induce AP sites in DNA. AP sites are non-coding. Therefore, copying an AP site by any DNA polymerase is error prone. Consequently, AP sites are highly mutagenic. In Escherichia coli, translesion synthesis of an AP site results in preferential insertion of an A opposite the lesion, leading to the 'A rule' hypothesis (1) . Such a strong bias opposite an AP site does not appear to be the case in mammals. Using plasmid mutagenesis systems, insertions of A, C, T and G opposite AP sites have all been reported in cultured mammalian cells (2) (3) (4) (5) (6) (7) . In yeast cells, whereas Lawrence and colleagues (8) observed predominant C insertion opposite AP sites, Haracska et al. (9) reported predominant A insertion.
Translesion synthesis, also referred to as lesion bypass, is the cellular process that directly copies damaged sites of the template during DNA synthesis. It consists of nucleotide insertion opposite the lesion and extension synthesis from opposite the lesion. According to this definition, a DNA polymerase that performs the insertion step, the extension step, or both, qualifies as a translesion polymerase. Extensive in vitro and some in vivo studies have indicated that Polz and the Y family polymerases are important translesion polymerases in eukaryotes [reviewed in (10) (11) (12) (13) (14) ]. Polz belongs to the same B family of DNA polymerases as the replicative Pola, Pold, and Pole (15, 16) . In the yeast Saccharomyces cerevisiae, the Y family consists of Polh and Rev1 (16) . Mammals contain two additional members of the Y family polymerases: Polk and Poli (10, 16) .
Rev1 possesses a dCMP transferase and is efficient in inserting a C opposite an AP site in vitro, but it cannot catalyze extension synthesis from opposite the lesion (17, 18) . The combination of Rev1 and Polz, however, results in bypass of the AP site in vitro (17) . Genetic experiments have shown that both Rev1 and Polz are required for AP site-induced mutagenesis in yeast cells (9, 19, 20) . Polz is believed to function in extension synthesis during AP site bypass (9, 17, 21) . The role of Rev1 in AP site bypass, however, is controversial. Whereas Lawrence and colleagues (19) concluded that Rev1 acts catalytically by inserting C opposite AP site, Haracska et al. (9) concluded that Rev1 predominantly plays a non-catalytic structural role.
Polh was originally discovered as an important translesion polymerase in response to UV-induced TT dimers in an errorfree manner (22, 23) . However, subsequent studies showed that yeast Polh is also responsive to template AP sites by catalysis of G and less frequently A insertions opposite the lesion in vitro (21) . Translesion synthesis of AP sites was later extended to the human Polh in vitro, although it prefers A to G for insertion opposite the lesion (24, 25) . Furthermore, we observed that sequential actions of Polh-catalyzed nucleotide insertion and Polz-catalyzed extension resulted in AP site bypass in vitro (21) . Thus, we proposed that Polh may be involved in error-prone translesion synthesis of some other DNA lesions such as AP sites (21) . Indeed, we found recently that Polh is involved in error-prone translesion synthesis of benzo[a]pyrene DNA adducts in yeast cells (26) .
To better understand mechanisms of translesion synthesis across AP sites in eukaryotes, we have performed in vitro biochemical and in vivo genetic experiments to examine the role of Polh in AP site bypass in yeast cells. In this report, we (i) describe a site-specific translesion synthesis assay in yeast cells; (ii) demonstrate that yeast Polh is involved in translesion synthesis of AP sites in vivo; and (iii) present evidence suggesting that an important role of Polh in AP site bypass is to catalyze extension synthesis following A insertion opposite the lesion.
MATERIALS AND METHODS

Materials
T4 DNA ligase, the T4 gene 32 protein, T4 polynucleotide kinase and yeast Polh were obtained from Enzymax (Lexington, KY). MMS was purchased from Sigma (St Louis, MO). Yeast Polz, and the catalytic subunits of yeast Pola and Pold were purified as previously described (27) (28) (29) . A 17mer DNA oligonucleotide containing a sitespecific tetrahydrofuran (AP site analog) was synthesized by automated DNA phosphoramidite methods by Operon (Alameda, CA). Its sequence is 5 0 -CGACTXGAAG-GATCCGC-3 0 , where X designates the AP site analog.
Other damaged and undamaged DNA oligonucleotides as indicated were synthesized by Integrated DNA Technologies (Coralville, IA). Yeast strains. The yeast strains used are the wild-type BY4741 (MATa his3 leu2 met15 ura3) and its isogenic BY4741Drad30 (rad30 deletion mutant), BY4741Drev1 (rev1 deletion mutant), BY4741Drev3 (rev3 deletion mutant), BY4741Drev1Drad30 (rev1 rad30 double deletion mutant) and BY4741Drev3Drad30 (rev3 rad30 double deletion mutant). BY4741 was purchased from ATCC (Manassas, VA). BY4741Drad30 (lacking Polh) was purchased from Research Genetics (Huntsville, AL). BY4741Drev3 (lacking Polz) and BY4741Drev3Drad30 were constructed as previously described (26) . BY4741Drev1 (lacking Rev1) was constructed by transforming BY4741 cells with a linearized rev1 deletion plasmid construct. The rev1 deletion clone was confirmed by a functional assay demonstrating reduced UV-resistance and loss of UV-induced mutagenesis. The rev1 deletion strain was further tested for complementation of UV resistance and UV-induced mutagenesis by a plasmid carrying the wild-type REV1 gene. BY4741Drev1Drad30 was similarly constructed by transforming BY4741Drad30 cells with the linearized rev1 deletion plasmid construct and similarly confirmed for its rev1 phenotype as described above.
Construction of plasmid containing a site-specific AP site
The plasmid vector used is pELUf1 ( Figure 1A ). The strategy for constructing pELUf1 containing a site-specific AP site is (B) Construction of pELUf1-AP containing a site-specific AP site. The AP site (indicated by a red dot) was carried on a 17mer oligonucleotide. Insertion of the damaged oligonucleotide into the unique NcoI site of the vector inactivated the URA3 gene, thus, allowing yeast cells containing replicated pELUf1-AP to grow on plates containing 5-FOA. The undamaged strand (shown in orange) of pELUf1-AP contained U in place of T. (C) In vivo translesion synthesis assay using the sitespecifically damaged pELUf1-AP plasmid. Transformation efficiency was measured in the same experiment by using undamaged pELUf1 and plates lacking both leucine and 5-FOA.
shown schematically in Figure 1B . Briefly, E.coli DH5aF 0 IQ cells containing plasmid pELUf1 were infected with the helper phage M13KO7, and a single-stranded pELUf1 was prepared. The single-stranded pELUf1 was annealed to a 20mer DNA oligonucleotide, 5 0 -GTGCCCTCCATGGAAAAATC-3 0 , at its unique NcoI restriction site within the vector URA3 gene, and digested with the NcoI restriction endonuclease. Then, the linearized single-stranded pELUf1 was annealed with a 46mer DNA scaffold, 5
0 -CTGUGCCCUCCAUGGCGGAU-TCUTCUAGUCGGAAAAAUCAGTCAAG-3 0 , and the 5 0 -phosphorylated 17mer oligonucleotide containing a sitespecific AP site. While the mid-region of the scaffold is complementary to the damaged oligonucleotide, its ends are complementary to the single-stranded pELUf1 ends. Ligation of the damaged oligonucleotide into the pELUf1 vector was performed with T4 DNA ligase at 16 C for 20 h, and DNA was precipitated in ethanol. Finally, the complementary strand of pELUf1 was synthesized with T4 DNA polymerase in the presence of T4 gene 32 protein and 0.5 mM each of dATP, dCTP, dGTP and dUTP, using the scaffold as the primer. The resulting construct, pELUf1-AP, was a double-stranded plasmid containing a site-specific AP site, in which the undamaged strand contained U in place of T. Furthermore, insertion of the damaged oligonucleotide inactivated the vector URA3 gene. Formation of double-stranded plasmid pELUf1-AP was confirmed by electrophoresis on a 1% agarose gel. Construction of pELUf1-AP was performed by Enzymax.
In vivo translesion synthesis assays in yeast
Undamaged pELUf1 or site-specifically damaged pELUf1-AP plasmid (2 mg) was transformed into yeast cells of various strains by the lithium acetate method essentially as described in (30) . Immediately after transformation, yeast cells were collected by centrifugation (20 s at 5000 r.p.m.) in a microcentrifuge. Cells transformed with the undamaged pELUf1 were resuspended in 1 ml of sterile water. Aliquots of 0.5-1 ml were diluted and plated onto YNB minimal agar plates (0.17% yeast nitrogen base, 0.49% ammonium sulfate, 2% glucose and 2% agar) lacking leucine to score for transformation efficiency (colonies containing replicated pELUf1). Cells transformed with the site-specifically damaged pELUf1-AP were resuspended in 400 ml of sterile water and were directly plated onto two YNB minimal agar plates lacking leucine but supplemented with 5 mM 5-fluoroorotic acid (5-FOA), 150 mM methionine, and 380 mM uracil to score for colonies containing replicated pELUf1-AP. Cells transformed by the undesired background plasmid pELUf1 without the damaged oligonucleotide insert remained the URA3 wild type and thus cannot grow on plates containing 5-FOA. After incubation at 30 C for 3-4 days, yeast colonies were counted. Translesion synthesis was calculated as transformants per microgram of the damaged plasmid per 10 6 transformable cells with the undamaged plasmid (i.e. transformants per microgram of the damaged plasmid · 10 6 /transformation efficiency expressed as transformants per microgram of the undamaged plasmid). Relative translesion synthesis was obtained by comparing translesion synthesis in various mutant strains to that in the wild-type cells.
Replicated pELUf1-AP plasmid clones were individually recovered from yeast colonies on the 5-FOA plates by a zymolyase method essentially as described in (31) and amplified in E.coli DH5a cells. Each pELUf1-AP plasmid clone was analyzed by digestion with the BamHI restriction endonuclease. A BamHI restriction site was designed into the damaged 17mer oligonucleotide during construction of pELUf1-AP. The BamHI restriction analysis further eliminated undesired background transformants by the undamaged pELUf1. These background transformants escaped selection by the 5-FOA plates because they contained mutations somewhere in the vector URA3 gene. Plasmid clones that did not contain this added BamHI restriction site were excluded from further analysis and calculation. Finally, the precise specificity of translesion synthesis opposite the site-specific AP site was determined by DNA sequencing.
DNA polymerase assays
A standard DNA polymerase reaction mixture (10 ml) contained 25 mM KH 2 PO 4 (pH 7.0), 5 mM MgCl 2 , 5 mM dithiothreitol, 100 mg/ml bovine serum albumin, 10% glycerol, 50 mM of dNTPs (dATP, dCTP, dTTP and dGTP individually or together as indicated), 50 fmol of an indicated DNA substrate containing a 32 P-labeled primer and a purified DNA polymerase as indicated. After incubation at 30 o C for 10 min, reactions were terminated with 7 ml of a stop solution (20 mM EDTA, 95% formamide, 0.05% bromophenol blue and 0.05% xylene cyanol). The reaction products were resolved on a 20% polyacrylamide gel containing 8 M urea and visualized by autoradiography. DNA synthesis products were quantitated by scanning densitometry using the SigmaGel software (Sigma) for analysis.
MMS sensitivity
Yeast cells grown at 30 C to stationary phase in minimum media were harvested by centrifugation, washed with sterile water and resuspended in 100 mM potassium phosphate (pH 7.0) to 4 OD 600 cells per milliliter. Cells were then treated with various doses of MMS as indicated at 30 C for 30 min with shaking, followed by centrifugation and washing with sterile water. After dilution, cells were plated in minimum medium plates. Surviving colonies were counted after incubation at 30 C for 2-4 days. Cell survival of each strain was expressed relative to that of untreated cells of the corresponding strain.
RESULTS
An in vivo translesion synthesis assay in yeast
To investigate mechanisms of AP site bypass in cells, we established a plasmid-based in vivo translesion synthesis assay in the yeast S.cerevisiae model system. The vector pELUf1 contains the yeast LEU2 gene for plasmid selection, the yeast URA3 gene for accepting a site-specifically damaged oligonucleotide and the f1 replication origin for production of single-stranded phagemid ( Figure 1A) . A 17mer oligonucleotide containing a site-specific AP site was ligated into the unique NcoI site of the single-stranded pELUf1 vector, with the help of a scaffold oligonucleotide. The resulting pELUf1-AP was then converted into double-stranded plasmid with T4 DNA polymerase, using the scaffold as the primer and dUTP instead of dTTP. The resulting undamaged second strand of pELUf1-AP contained U in place of T ( Figure 1B) .
The site-specifically damaged pELUf1-AP was transformed into yeast cells ( Figure 1C ). Using double-stranded DNA ensured efficient transformation. High levels of U in DNA will lead to extensive DNA fragmentation initiated by uracil-DNA glycosylase (UDG) (32) (33) (34) . Thus, the U-containing DNA strand was quickly destroyed by the combined actions of UDG and AP endonucleases as the plasmid entered into cells, converting the double-stranded plasmid back into single-stranded DNA. Consequently, plasmid propagation in cells could only be achieved by replicating the damaged DNA strand involving translesion synthesis. Transformed cells were plated on minimal media plates containing uracil and 5-FOA but lacking leucine. While plates without leucine allowed selection for the replicated plasmid, 5-FOA was used to select for ura3 mutant cells. Since insertion of the damaged oligonucleotide had inactivated the URA3 gene, cells containing plasmid pELUf1-AP from translesion synthesis were able to grow on the 5-FOA plate. In contrast, cells transformed by the undesired intact pELUf1 without the oligonucleotide insert remained the URA3 wild type and were therefore unable to grow on the 5-FOA plate. Transformation efficiency was determined by using undamaged and double-stranded pELUf1 plasmid in the same experiment. After correcting for differences in transformation efficiency, translesion synthesis efficiency in various cells relative to that in the wild-type cells was calculated. Replicated plasmid clones were individually isolated from yeast colonies and subsequently amplified in E.coli. To further ensure that the plasmid clones were indeed derived from translesion synthesis in yeast cells, a BamHI site was designed into the damaged oligonucleotide, whereas its complementary scaffold DNA contained a mismatch eliminating this restriction site on the undamaged strand. After amplification in E.coli, each plasmid clone was digested with BamHI. Clones without this BamHI site were excluded from further analysis. Each clone was sequenced to identify the nucleotide inserted opposite the AP site ( Figure 1C ).
Polh is involved in translesion synthesis of AP sites in yeast cells
To determine whether Polh is involved in AP site bypass in cells, we performed in vivo translesion synthesis assays in yeast strains proficient or deficient in Polh. Since Polz and Rev1 are known to be required for translesion synthesis of AP sites in cells (9, 19, 20) , we also performed in vivo translesion synthesis assays in mutant cells lacking Polz (rev3 deletion mutant) or Rev1 for comparison. As expected, translesion synthesis of the site-specific AP site was reduced to 30 and 15% of the wild-type level in rev1 and rev3 mutant cells, respectively (Figure 2 ). In rad30 mutant cells lacking Polh, translesion synthesis was reduced to 30% of the wildtype level (Figure 2 ). These results show that Polh is involved in translesion synthesis of AP sites in yeast.
To gain insights into the genetic relationship between Polh and Rev1 or Polz in AP site bypass, we performed translesion synthesis assays in yeast cells lacking both Polh and Rev1 or both Polh and Polz. If Polh functions in the same bypass pathway with Rev1 and Polz, translesion synthesis in the double mutant would not be further reduced as compared with the single mutants. If the Polh function in AP site bypass involves another mechanism different from that of Rev1 and Polz, translesion synthesis would be more deficient in the double mutant than in the respective single mutants. As shown in Figure 2 , translesion synthesis in the rev1 rad30 double mutant cells was reduced further, as compared to the respective single mutant strains. In the rev3 rad30 double mutant cells, translesion synthesis was severely deficient, retaining only 3% of that in wild-type cells (Figure 2 ). These results suggest that the Polh function in AP site bypass involves another mechanism different from the bypass mechanism mediated by the Polz mutagenesis pathway.
Specificity of in vivo translesion synthesis opposite AP sites
To further understand the role of Polh in AP site bypass, we recovered the replicated plasmids from yeast clones and individually amplified them in E.coli for DNA sequencing. Three types of translesion products were observed from various yeast strains: (i) simple translesion synthesis in that 1 nt was inserted, or a À1 deletion was produced, opposite the AP site; (ii) following translesion synthesis opposite the AP site, another mutation was generated downstream of the lesion; and (iii) complex translesion synthesis in that multiple mutations were generated on both sides of the AP site ( Figure 3 ). Translesion synthesis with downstream mutations was rare. Only 2 such clones out of 60 from cells lacking Polh, 1 out of 29 clones from wild-type cells and 1 out of 27 clones from the rev1 mutant cells were recovered.
T insertion opposite the AP site was not observed among all yeast strains examined. In wild-type cells (Table 1) , the majority of translesion synthesis (62%) resulted from C insertion opposite the AP site. Less frequently (21%) A was inserted opposite the lesion. A small fraction (14%) of the bypassed products were derived from complex translesion synthesis, while À1 deletion occurred only as a very minor event (3%). G was not recovered opposite the AP site. In rad30, rev1, rev3, rev1 rad30 and rev3 rad30 mutant cells, the spectra of translesion synthesis were significantly altered (Table 1 ). In cells lacking either Rev1 or Polz, C insertion opposite the AP site was not detected (Table 1 ). In rad30 mutant cells lacking Polh, A insertion was favored over C insertion opposite the AP site (Table 1) . Furthermore, G insertion opposite the lesion became detectable in rev3 (lacking Polz) or rad30 mutant cells ( Table 1) .
When the altered bypass in the mutant strains was directly compared to AP site bypass in wild-type cells, expressed as translesion synthesis relative to that in wild-type cells, the effects of Polh, Rev1 and Polz became more clear ( Table 2 ). For AP site bypass with C incorporation, while Rev1 and Polz were indispensable, Polh had a strong stimulatory effect (Table 2 ). In contrast, AP site bypass with A incorporation remained as the most frequent mechanism in cells lacking Polh, Rev1 or Polz, although such bypass frequency was reduced by approximately 2-fold in these mutant cells (Table 2 ). This type of translesion synthesis became largely abolished only when both the Polh and Rev1 or both the Polh and Polz activities were eliminated (Table 2) . AP site bypass with À1 deletion was not significantly affected in cells lacking Polh, Rev1 or Polz, but was abolished in cells lacking both Polh and Polz ( Table 2 ). The complex translesion product was significantly reduced in cells lacking Polz and abolished in cells lacking both Polz and Polh (Table 2 ). These results suggest that Polh is generally involved in AP site bypass in yeast cells but it acts in a mechanism(s) different from the Polz mutagenesis pathway that involves Rev1 and Polz.
In vitro activities of Polh in response to a template AP site Our genetic assay is an endpoint measurement that includes the two distinct steps of in vivo translesion synthesis: nucleotide insertion and extension. Hence, the genetic assay cannot assign the observed effect to either the insertion or extension step, or both. To better define the roles of Polz and Polh in AP site bypass, we examined in vitro activities of both polymerases in response to an AP site. As shown in Figure 4A , the AP site strongly blocked yeast Polz in vitro ( Figure 4A , lane 1). Nevertheless, weak insertion activity was detected with purified Polz, which inserted a G opposite the AP site ( Figure 4A Figure 4B ). Subsequent extension synthesis, however, was inefficient ( Figure 4B, lane 1) . The Polh results are similar to our earlier observation with another AP site in a different sequence context where the template base immediately 5 0 to the lesion was an A (21). Since G insertion opposite the AP site was not detected during in vivo translesion synthesis in wildtype cells (Table 1) , we conclude that neither Polh nor Polz is significantly involved in catalyzing nucleotide insertion opposite the AP site in yeast cells. Apparently, the intrinsic G insertion activity of Polh was not employed to a significant extent for in vivo bypass of AP sites even in the absence of Rev1 or Polz (Tables 1 and 2 ). b Number of independent clones sequenced following in vivo translesion synthesis assays using pELUf1-AP plasmid containing a site-specific AP site. Only two clones were recovered from the rev3 rad30 double mutant cells. c Number of various translesion synthesis products are shown. The percentage of a particular type of TLS among all of the bypassed products in a strain is shown in the parenthesis. d The À1 deletion. e Only one type of complex TLS was observed, which contained mutations on both sides of the AP site. The precise sequence of the complex TLS product is shown in Figure 3 . To examine a possible role of Polh in extension synthesis, we separately annealed four 32 P-labeled 17mer primers to the damaged template, terminating with an A, C, T or G, respectively, opposite the lesion ( Figure 5A ). DNA synthesis assays were then performed with purified yeast Polh. For comparison, similar experiments were also performed with an undamaged template G opposite the primer 3 0 end ( Figure 5A ). As expected, Polh was capable of extension synthesis from matched and mismatched primer 3 0 end with varying efficiencies ( Figure 5A, lanes 1 to 4) . The full-length extension products (22mer DNA band) were generated from the T-G (primer-template) and G-G mismatches ( Figure 5A, lanes 3  and 4) . However, extension of the A-G mismatch yielded predominantly 1 nt shorter products (21mer DNA band) ( Figure 5A , lane 1), indicating that extension was mainly mediated by a À1 deletion mechanism through Polh-catalyzed realignment of the primer 3 0 A with the next template T prior to extension synthesis. In response to a template AP site, extension synthesis was observed with Polh from the primer 3 0 A opposite the lesion, generating both full-length and À1 deletion products in similar quantities ( Figure 5A, lane 5) . Extension was ineffective from the primer 3 0 G opposite the AP site ( Figure 5A, lane 8) , and was not detected from the primer 3 0 C or T ( Figure 5A, lanes 6 and 7) . To determine whether extension from A opposite the AP site requires a template T immediately 5 0 to the lesion, we performed the extension assay again with another DNA substrate containing a template G immediately 5 0 to the AP site. As shown in Figure 5B (lanes 3 to 7) , extension by Polh was also observed from A opposite the AP site, generating predominantly full-length products. Furthermore, the extension activity of Polh was comparable to that of purified yeast Polz ( Figure 5B , lane 2). Since Polz is inefficient in copying the last template base even from undamaged templates (27, 29) , the 35mer extension product of Polz ( Figure  5B , lane 2) most likely resulted from a normal extension mechanism rather than a À1 deletion mechanism. These results show that Polh possesses a significant biochemical activity of extension synthesis from a primer 3 0 A opposite an AP site. (Tables 1 and 2 ). Thus, it is possible that a replicative polymerase such as Pola or Pold may be important for A insertion opposite AP sites in yeast cells. To test this possibility, we annealed a 16mer primer to the damaged template, terminating right before the AP site ( Figure 6 ). DNA synthesis assays were then performed using the purified catalytic subunits of yeast Pola and Pold. As shown in Figure 6 (lanes 2 to 6), Pola efficiently inserted an A opposite the AP site, but was unable to extend it. In contrast, Pold was very inefficient in A insertion opposite the AP site ( Figure 6 , lanes 8 to 12), and extension from opposite the lesion was not detected. Nucleotide insertion by Pold opposite the AP site was further reduced in the presence of dATP alone ( Figure 6 , compare lanes 8 and 9). Moreover, nuclease activities were apparent when the translesion synthesis reactions were performed using dATP, dTTP or dGTP alone ( Figure 6 , lanes 9, 11 and 12). Therefore, it is possible that A insertion opposite the AP site may be greatly suppressed by the 3 0 !5 0 proofreading exonuclease activity of Pold. To test this possibility, we determined whether A opposite the AP site is subject to removal by the proofreading exonuclease activity of Pold. We labeled a 17mer primer with 32 P at its 5 0 end and annealed it to the damaged template with the primer 3 0 A terminating opposite the AP site (Figure 7 ). Purified yeast Pold was then incubated with this DNA substrate in the absence of deoxyribonucleoside triphosphates. DNA substrates Figure 2 and Table 1 . The À1 deletion. d Only one type of complex TLS was observed, which contained mutations on both sides of the AP site. The precise sequence of the complex TLS product is shown in Figure 3. containing a C-G (primer-template) base pair or an A-G mismatch at the primer 3 0 end were used as controls. As shown in Figure 7 , the 3 0 !5 0 proofreading exonuclease of Pold was active in removing the A-G mismatch (60% removal), but inactive against the C-G base pair (compare lanes 7 and 8) at the primer 3 0 end. The primer 3 0 A opposite the AP site was also actively removed by the 3 0 !5 0 proofreading exonuclease of Pold (68% removal) to a similar extent as the A-G mismatch (Figure 7, compare lanes 2 and 6) . The primer 3 0 C opposite the AP site, however, was more resistant to the 3 0 !5 0 proofreading exonuclease of Pold (38% removal) ( Figure 7, lane 4) . These results show that, while Pola is capable of efficiently inserting an A opposite the AP site, Pold is much less effective in A insertion opposite the lesion due to its 3 0 !5 0 proofreading exonuclease activity.
Cellular resistance to MMS conferred by Polh, Polz and Rev1
Genetic studies have demonstrated that defects in translesion synthesis result in cellular sensitivity to DNA-damaging agents. For example, Polh, Polz and Rev1 play major roles in translesion synthesis in response to UV radiation (22, 23, 36, 37) . Consequently, their corresponding mutant cells are hypersensitive to UV radiation (36) (37) (38) (39) (40) . Based on our results that Polh plays a significant role in the bypass of AP sites in yeast cells, we predicted that rad30 mutant cells lacking Polh would be sensitive to AP site-inducing agents. Even though there is not a known agent that specifically induces AP site in DNA, MMS is probably the most effective agent for AP site induction. As is the case of UV radiation, MMS induces multiple types of DNA lesions. Nevertheless, AP sites are induced by MMS as a major type of lesion, since it reacts with DNA forming mainly unstable N 3 -methyladenine and N 7 -methyl guanine adducts, which readily depurinate to AP sites (41, 42) . To test our prediction, we determined cellular sensitivity to MMS treatment in the presence or absence of Polh. For comparison, rev1 and rev3 mutant cells were also included in these experiments. As expected, Rev1 and rev3 mutant cells were sensitive to MMS treatment as compared to the wild-type cells (Figure 8) . Furthermore, the survival curve of rev1 and rev3 mutant cells were essentially identical (Figure 8) , consistent with the notion that Rev1 and Polz function in the same Polz mutagenesis pathway for AP site bypass. Similarly, rad30 mutant cells were also sensitive to MMS treatment (Figure 8 ). In the absence of both Rev1 and Polh, the rev1 rad30 double mutant cells became much more sensitive to MMS than either of the single mutant strains (Figure 8 ). In the absence of both Polz and Polh, the rev3 rad30 double mutant cells were much more sensitive to MMS 3 to 7) . Products of DNA synthesis were separated by 20% denaturing polyacrylamide gel and visualized by autoradiography of the gel. DNA size markers in nucleotides are indicated on the sides. X, the AP site.
than either of the single mutant strains, and exhibited more sensitivity than the rev1 rad30 double mutant (Figure 8 ). These results show that Polh, like Polz and Rev1, confers cellular resistance to MMS and that the function of Polh in response to MMS does not completely overlap with the Polz mutagenesis pathway. These results further support our conclusion that Polh plays a significant role in AP site bypass in yeast cells.
DISCUSSION
In this study, we have examined the role of Polh in translesion synthesis of AP sites in yeast cells. In vivo translesion synthesis was directly examined through replication of a plasmid containing a site-specific AP site. A similar assay in yeast cells was originally developed by Lawrence and colleagues (43) using single-stranded plasmid DNA containing a site-specific lesion. Owing to the extremely low transformation efficiency of single-stranded plasmid in yeast cells, the in vivo assay was later modified by using a double-stranded plasmid containing a site-specific lesion located in a small gap (8) . This in vivo translesion synthesis assay essentially measures a gap filling reaction in yeast. Nevertheless, the gap filling reaction did reflect translesion synthesis as indicated by a genetic requirement for Polz and Rev1 (19) . In our assay system, a significant modification was made in that the site-specifically damaged and single-stranded plasmid was converted into the doublestranded form prior to transformation, replacing T with U during in vitro synthesis of the complementary strand. Upon entering into cells, the complementary strand was degraded as a result of replacement of T by U, thus, converting the plasmid DNA back into single-stranded form containing a site-specific lesion. An advantage of our system is that replication of the damaged plasmid specifically reflects translesion synthesis without the interference by DNA repair, a template switching mechanism, recombination or selective replication of the undamaged complementary strand. Our experiments were designed such that if the complementary strand were replicated, a T would have been inserted at the position corresponding to the opposite of the original AP site. This was not observed, thus, supporting our expectation that the complementary strand cannot be replicated due to its degradation inside cells. Like earlier systems (19, 44) , our in vivo translesion synthesis assays also reflected a genetic requirement for Polz and Rev1 that are known to be required for translesion synthesis of AP sites in cells.
Using our in vivo translesion synthesis assay, we found that Polh makes a significant contribution to AP site bypass in yeast cells. Without Polh, translesion synthesis of AP sites is significantly impaired. Furthermore, the specificity of nucleotide insertion opposite the AP site is altered in rad30 mutant cells lacking Polh. Yeast Polh is capable of inserting a G and less frequently an A opposite an AP site in vitro, regardless of whether a template T or a template A is located immediately 5 0 to the lesion (21) ( Figure 4B ). Thus, if Polh participates in AP site bypass by catalyzing nucleotide insertion opposite the lesion, then, significant G insertion opposite the AP site should be recovered from the replicated plasmids in wild-type cells. This was not the case. Only C and A insertions were detected among the bypassed products in wild-type cells, accounting for 62 and 21%, respectively, of the total bypassed products. Even in the rev1 or rev3 mutant cells that lack the Polz mutagenesis pathway, G was still not significantly inserted opposite the AP site. Similarly, G insertion opposite the AP site was not observed in a study by Nelson et al. (19) . Therefore, although Polh possesses an intrinsic biochemical activity of G insertion opposite AP sites, this activity is not significantly recruited for translesion synthesis of AP sites in vivo. This underscores the importance of performing in vivo genetic experiments to validate the in vitro biochemical results obtained from the various translesion polymerases. Nevertheless, it is possible that Polh may play a minor role in catalyzing G and A insertions opposite AP sites, but G was less effectively extended than A by Polz (9) . In such a case, Polh would make a small contribution to the detected A insertion during AP site bypass in yeast cells.
Then, what is the major role of Polh in translesion synthesis of AP sites in yeast cells? Our genetic and biochemical results together suggest that an important role of Polh in AP site bypass is to catalyze extension synthesis from the primer 3 0 A opposite the lesion. This activity was detected by in vitro biochemistry, and was supported by in vivo results that A insertion opposite the AP site was reduced approximately 2-fold in rad30 mutant cells as compared to the wild-type cells (Table 2) . We found that extension from opposite the AP site by Polh was most efficient from the primer 3 0 A, much less efficient from the primer 3 0 G, and not detected from the primer 3 0 C or T ( Figure 5A ). These biochemical properties are also observed with the human Polh (45) . Additionally, our genetic experiments suggest that Polh facilitates AP site bypass with C insertion in yeast cells (Table 2 ). Since Polh is unable to perform effective C insertion or extension synthesis from C opposite the AP site, this polymerase may somehow facilitate Rev1-catalyzed C insertion opposite the lesion. Most recently, it was reported that mouse Polh physically interacts with mouse Rev1 at its C-terminal region (46) . Whether there exists a similar interaction between the yeast proteins and whether such an interaction is involved in the putative stimulatory action of Polh on the Rev1 dCMP transferase remain to be determined.
Rev1 efficiently inserts a C opposite a template AP site in vitro (17, 18, 35) . In vivo, C insertion opposite the AP site was abolished in rev1 mutant cells. Therefore, in wild-type cells, C insertion opposite the AP site is catalyzed by the Rev1 dCMP transferase. The subsequent extension synthesis, however, requires another polymerase. In vitro, Polz is capable of extension synthesis from opposite an AP site (9, 17, 21) . Thus, it is believed that Polz is an important extension polymerase during translesion synthesis (9, 17, 21) . Consistent with this notion, C insertion was also abolished in rev3 mutant cells, and A insertion was reduced by approximately 2-fold opposite the AP site. In cells lacking Polz, the significant residual extension activity from 3 0 A opposite the AP site probably resulted from Polh activity. Supporting this interpretation, AP site bypass with A insertion opposite the lesion was nearly abolished in cells lacking both Polz and Polh.
In mutant cells lacking Polh, Polz or Rev1, A was still significantly inserted opposite the AP site. Thus, a replicative polymerase is likely responsible for the A insertion opposite the AP site in yeast cells. Indeed, opposite an AP site, Pola possesses a significant A insertion activity and Pold has a weak A insertion capacity in vitro (Figure 7 ) (9). Since A insertion by Pold is greatly limited by its 3 0 !5 0 proofreading exonuclease activity, Pola likely plays a significant role in A insertion opposite the AP site in yeast cells. The rare G insertions in the rad30 and rev3 mutant cells (Table 2) were likely catalyzed by Polz and Polh, respectively. The precise mechanism of complex translesion synthesis involving base substitutions and deletions on both sides of the AP site is not clear. Nevertheless, Polz and Polh may be involved, as indicated by a reduction of this type of bypass products in the respective mutant strains (Table 2) .
Taken together both in vitro and in vivo results, we propose a model for translesion synthesis of AP sites in yeast cells as shown in Figure 9 . In our model, most AP sites in DNA block the replicative polymerases before the lesion. Thus, a major mechanism of translesion synthesis is mediated by C insertion opposite the AP site catalyzed by Rev1 and somehow facilitated by Polh. Then, translesion synthesis is completed by Polz-catalyzed extension ( Figure 9 ). There is another parallel mechanism for translesion synthesis of AP sites, in which Pola and Pold insert A opposite the lesion. Polh may also contribute to a small fraction of A insertions opposite the lesion. Subsequent extension synthesis is then catalyzed independently by Polz and Polh ( Figure 9 ). Rev1 probably plays an accessory role for Polz-catalyzed extension from the primer 3 0 A opposite the AP site ( Figure 9 ). The precise role of Rev1, however, is not known. Supporting a role of Rev1 in Polzcatalyzed extension, A insertion was reduced by approximately 2-fold in the rev1 mutant cells and was largely abolished in rev1 rad30 double mutant cells (Table 2) , suggesting a synergistic effect of Rev1 and Polh in extension synthesis from A-terminated primers opposite AP sites. In the rev3 rad30 double mutant cells, extensions in the two paralleled bypass mechanisms are completely blocked, leading to the most severe defect in AP site bypass, as indicated by results from both the in vivo translesion synthesis experiments and the cellular sensitivity to MMS.
Lawrence and colleagues (8, 19) originally reported that Rev1-catalyzed C insertion opposite the lesion was the predominant mechanism of AP site bypass in yeast cells. However, Haracska et al. (9) recently concluded that Poldcatalyzed A insertion was the major mechanism of AP site bypass. Our model of AP site bypass could provide an explanation for these conflicting reports. Our studies and those of Lawrence and colleagues with wild-type cells were performed under normal growth conditions, thus yielding similar results of AP site bypass. Haracska et al. (9) , however, performed their experiments with the anp1 apn2 double mutant strain under MMS treatment conditions that killed nearly all cells (<0.3% cell survival). The double mutant cells are unable to repair AP sites in DNA. Hence, MMS treatment of these cells would yield excessive unrepaired AP sites in the genome during replication. Excessive AP sites may lead to saturation of the Rev1-catalyzed C insertion mechanism ( Figure 9 ). Consequently, the majority of AP sites would have to be bypassed by the Pola-catalyzed A insertion mechanism (Figure 9) , resulting in predominant A insertion opposite AP sites under the experimental conditions of Haracska et al. (9) .
As indicated by our results and our model (Figure 9 ), AP site bypass in yeast cells is a complex cellular process involving different mechanisms and multiple polymerases. Such complexity offers some levels of functional redundancy. Indeed, some residual levels of AP site bypass can still take place in the absence of any single translesion polymerase. In higher eukaryotes, AP site bypass is further complicated by the presence of two more Y family translesion polymerases: Polk and Poli, which efficiently and predominantly insert an A and a G, respectively, opposite a template AP site in vitro (47) (48) (49) . Thus, these two polymerases may participate in nucleotide insertion during AP site bypass in mammalian cells. Furthermore, Polk is able to perform efficient extension synthesis by a À1 deletion mechanism in certain sequence contexts in vitro (47, 49) , raising the possibility that it may also participate in extension synthesis to some extent from the primer 3 0 A opposite the AP site. A better understanding of AP site bypass in higher eukaryotes should be facilitated by genetic analyses as we have performed and the conceptual model we have generated here in the yeast model system. In one mechanism (scheme on the left side), the replicative polymerase is blocked by the lesion and subsequently replaced by Rev1. C insertion is catalyzed by Rev1 and stimulated by Polh. Bypass is completed by Polz-catalyzed extension from opposite the lesion. In the other mechanism (scheme on the right), A is inserted opposite the AP site by Pola and Pold. Polh may also catalyze A insertion to a limited extent. Extension is then catalyzed independently by Polz or Polh. Rev1-catalyzed C insertion may be facilitated by Polh, and Polz-catalyzed extension may be facilitated by Rev1, although the precise nature of such facilitation is not clear yet.
